{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:59:40Z","timestamp":1791251980712,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.eururo.2010.11.038","type":"journal-article","created":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T04:18:32Z","timestamp":1291781912000},"page":"438-446","source":"Crossref","is-referenced-by-count":48,"title":["Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Gu\u00e9rin and with Bacillus Calmette-Gu\u00e9rin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)"],"prefix":"10.1016","volume":"59","author":[{"given":"Willem","family":"Oosterlinck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziya","family":"Kirkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Calais da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2010.11.038_bib0005","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2005.05.011","article-title":"EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ","volume":"48","author":"van der Meijden","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00299720","article-title":"Cytostatic effect of different strains of Bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha","volume":"20","author":"Rajala","year":"1992","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2010.11.038_bib0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000282576","article-title":"Trial with bacillus Calmette-Guerin and epirubicin combination in the prophylaxis of superficial bladder cancer","volume":"52","author":"Erol","year":"1994","journal-title":"Urol Int"},{"issue":"Suppl","key":"10.1016\/j.eururo.2010.11.038_bib0030","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/BF00686923","article-title":"The effects of intravesical chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin for prophylaxis of recurrence of superficial bladder cancer: a preliminary report","volume":"35","author":"Uekado","year":"1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0035","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000020171","article-title":"Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer","volume":"37","author":"Bono","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","article-title":"One-sample multiple testing procedure for phase II clinical trials","volume":"38","author":"Fleming","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.eururo.2010.11.038_bib0045","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","article-title":"The role of bacillus Calmette-Gu\u00e9rin in the treatment of non\u2013muscle-invasive bladder cancer","volume":"57","author":"Gontero","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0050","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0055","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0022-5347(01)66691-6","article-title":"Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group","volume":"154","author":"Rintala","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0060","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0022-5347(01)62377-2","article-title":"Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer","volume":"160","author":"Witjes","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0065","first-page":"199","article-title":"Marker tumour response to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours: Report from the European Organisation for Research and Treatment on Cancer-Genitourinary Group (EORTC 30897)","volume":"29","author":"Van der Meijden","year":"1996","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5347(01)65936-6","article-title":"Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer","volume":"156","author":"Rintala","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0075","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000049765","article-title":"Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861","volume":"40","author":"Jakse","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.ju.0000150425.09317.67","article-title":"Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer\u2013Genito-Urinary Group Phase III Trial (30906)","volume":"173","author":"de Reijke","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0302-2838(03)00140-4","article-title":"Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a Nordic study","volume":"43","author":"Kaasinen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0302-2838(02)00260-9","article-title":"Factors explaining recurrence in patients undergoing chemoimmunotherapy regimens for frequently recurring superficial bladder carcinoma","volume":"42","author":"Kaasinen","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.juro.2008.03.038","article-title":"Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with non-muscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study","volume":"180","author":"Cai","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(05)70472-1","article-title":"Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial","volume":"7","author":"Di Stasi","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2010.11.038_bib0105","doi-asserted-by":"crossref","unstructured":"El Mohsen MA, Shelbaia A, El Ghobashy S, et al. Sequential chemoimmunotherapy using Mitomycin followed by bacillus Calmette-Gu\u00e9rin versus single agent immunotherapy (BCG) for recurrent superficial bladder tumors. UroToday Int J 2010;3. doi:10.3834\/uij.1944-5784.2010.06.06.","DOI":"10.3834\/uij.1944-5784.2010.06.06"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283810011401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283810011401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T05:28:00Z","timestamp":1544074080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283810011401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0302283810011401"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2010.11.038","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}